Seeking Alpha

Hikma Pharmaceuticals plc. ADR (HKMPY)

- OTCPK - Current
  • May 28, 2014, 8:27 AM
    • Hikma Pharmaceuticals (HKMPF) has agreed to buy the U.S. generic injectable drugs business of Germany's Boehringer Ingelheim for up to $300M, as it attempts to boost its "injected medicine" market share.
    • The company will pay $225M upfront for the assets of Boehringer's Bedford Laboratories and another $75M over the course of five years based on the performance of the drugs.
    | Comment!
  • Nov. 23, 2011, 1:59 PM
    Aeterna Zentaris (AEZS +1.8%) gains after saying it's signed an exclusive agreement for the registration and marketing of perifosine in the Middle East and North Africa with Hikma Pharmaceuticals (HKMPY.PK).
    | Comment!
Visit Seeking Alpha's
HKMPY vs. ETF Alternatives
Company Description
Currently, there's no company description for HKMPY.